Aminopyridine derivatives having aurora a selective inhibitory action
    5.
    发明授权
    Aminopyridine derivatives having aurora a selective inhibitory action 有权
    具有极光选择性抑制作用的氨基吡啶衍生物

    公开(公告)号:US08367690B2

    公开(公告)日:2013-02-05

    申请号:US13259620

    申请日:2010-03-15

    IPC分类号: A01N43/54 A61K31/505

    摘要: The present invention relates to a compound of Formula (I): wherein: R1 is H, —NHCOOR1a, C5-6 cycloalkyl, or phenyl; where the cycloalkyl and phenyl each independently may be substituted with one to three of the same or different substituents selected from R10; R1a is C1-3 alkyl which may be substituted with one to three of the same or different substituents selected from F and Cl; R2 is H, —COOH, —CH2 COOH, —COOR2a, or —CH2COOR2a; R2a is C1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from halogen atoms; R3 is H, C1-6 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R11; R10 is F, Cl, CF3, or C1-2 alkyl; R11 is halogen atom, hydroxy, or cyano; W is selected from: W2a is H, halogen atom, cyano, C1-2 alkyl, or C3-5 cycloalkyl, or a pharmaceutically acceptable salt or ester thereof.

    摘要翻译: 本发明涉及式(I)的化合物:其中:R1是H,-NHCOOR1a,C5-6环烷基或苯基; 其中环烷基和苯基各自独立地可以被一至三个相同或不同的选自R 10的取代基取代; R 1a是可以被一至三个相同或不同的选自F和Cl的取代基取代的C 1-3烷基; R2是H,-COOH,-CH2COOH,-COOR2a或-CH2COOR2a; R2a是C1-2烷基,其中烷基可以被一至三个相同或不同的选自卤素原子的取代基取代; R3是H,C1-6烷基,其中烷基可以被一至三个相同或不同的选自R11的取代基取代; R 10是F,Cl,CF 3或C 1-2烷基; R11是卤素原子,羟基或氰基; W选自:W2a是H,卤素原子,氰基,C1-2烷基或C3-5环烷基,或其药学上可接受的盐或酯。

    NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION
    6.
    发明申请
    NOVEL AMINOPYRIDINE DERIVATIVES HAVING AURORA A SELECTIVE INHIBITORY ACTION 有权
    具有选择性抑制作用的新型氨基吡啶衍生物

    公开(公告)号:US20120015969A1

    公开(公告)日:2012-01-19

    申请号:US13259620

    申请日:2010-03-15

    摘要: The present invention relates to a compound of Formula (I): wherein: R1 is H, —NHCOOR1a, C5-6 cycloalkyl, or phenyl; where the cycloalkyl and phenyl each independently may be substituted with one to three of the same or different substituents selected from R10; R1a is C1-3 alkyl which may be substituted with one to three of the same or different substituents selected from F and Cl; R2 is H, —COOH, —CH2 COOH, —COOR2a, or —CH2COOR2a; R2a is C1-2 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from halogen atoms; R3 is H, C1-6 alkyl, where the alkyl may be substituted with one to three of the same or different substituents selected from R11; R10 is F, Cl, CF3, or C1-2 alkyl; R11 is halogen atom, hydroxy, or cyano; W is selected from: W2a is H, halogen atom, cyano, C1-2 alkyl, or C3-5 cycloalkyl, or a pharmaceutically acceptable salt or ester thereof.

    摘要翻译: 本发明涉及式(I)的化合物:其中:R1是H,-NHCOOR1a,C5-6环烷基或苯基; 其中环烷基和苯基各自独立地可以被一至三个相同或不同的选自R 10的取代基取代; R 1a是可以被一至三个相同或不同的选自F和Cl的取代基取代的C 1-3烷基; R2是H,-COOH,-CH2COOH,-COOR2a或-CH2COOR2a; R2a是C1-2烷基,其中烷基可以被一至三个相同或不同的选自卤素原子的取代基取代; R3是H,C1-6烷基,其中烷基可以被一至三个相同或不同的选自R11的取代基取代; R 10是F,Cl,CF 3或C 1-2烷基; R11是卤素原子,羟基或氰基; W选自:W2a是H,卤素原子,氰基,C1-2烷基或C3-5环烷基,或其药学上可接受的盐或酯。